Mapping Auricular Vagus Nerve Circuitry
Auricular Vagal Nerve Stimulation for Gastric and Brain Outcomes
2 other identifiers
interventional
50
1 country
1
Brief Summary
This study will determine how noninvasive nerve stimulation affects human brain, stomach, and autonomic activity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for early_phase_1 healthy
Started Aug 2023
Longer than P75 for early_phase_1 healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 20, 2005
CompletedStudy Start
First participant enrolled
August 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2028
October 24, 2025
October 1, 2025
4.9 years
September 13, 2005
October 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Brain activity during functional magnetic resonance imaging (fMRI)
Blood oxygen-level dependent (BOLD) signal change between active and inactive auricular tVNS
1 hour
Stomach activity during gastric magnetic resonance imaging (MRI)
Gastric accommodation and sensitivity change between active and inactive auricular tVNS
30 minutes
Secondary Outcomes (4)
Electrogastrography (EGG)
2 hours
Electrocardiography (ECG)
2 hours
Respiration
2 hours
Skin Conductance Levels (SCL)
2 hours
Study Arms (2)
Congruent
EXPERIMENTALParticipants receive briefings on expectations of stimulation effects on gastric motility consistent with the literature.
Incongruent
EXPERIMENTALParticipants receive briefings on expectations of stimulation effects on gastric motility inconsistent with the literature.
Interventions
non-painful active transcutaneous electro-acupoint stimulation will be delivered to the abdomen and leg
Eligibility Criteria
You may qualify if:
- Adults 18-65
- Functional dyspepsia
You may not qualify if:
- Any condition contraindicating an fMRI brain scan
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Vitaly Napadow, PhD
Harvard University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants are not made aware of the expectation manipulation nor their group assignment until the end of the final visit, at which point they are debriefed. Outcomes assessors will be blind to group assignments until analysis is complete.
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 20, 2005
Study Start
August 22, 2023
Primary Completion (Estimated)
June 30, 2028
Study Completion (Estimated)
June 30, 2028
Last Updated
October 24, 2025
Record last verified: 2025-10